Asia · Markets & Finance · CNBC-TV18

Aurobindo Pharma gets USFDA final approval for Perampanel tablets

Published by CNBC-TV18 · India 3 h ago

Drugmaker to launch the approved product in Q3 FY27; product has estimated US market size of $67 million, according to IQVIA MAT

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

The Economic Times

‘God Made Trump’: 13 taxpayer-funded ads revealed

Business Standard

Parliamentary panel may recommend govt for action on monitoring crypto

25 rising startups in Thailand

Trump promises $5,000 to US adults if Republicans win 2026 midterms

Vietnam targets 1.5% GDP contribution from low-altitude economy by 2045

The Financial Express

A Hyderabadi biryani that sings, not shouts